Integrated Filing — IndAS



General information about company

Scrip Code 524816
NSE Symbol NATCOPHARM
MSEI Symbol NOTLISTED
ISIN INE987B01026
Name of company NATCO PHARMA LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 13-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 29-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 13-11-2026   11:50:00
End date and time of board meeting 13-11-2026   14:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 96,730.00 1,70,250.00
Other income 5,210.00 11,130.00
Total income 1,01,940.00 1,81,380.00
2 Expenses
(a) Cost of materials consumed 17,170.00 32,950.00
(b) Purchases of stock-in-trade 8,180.00 10,960.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (7,040.00) (10,850.00)
(d) Employee benefit expense 20,360.00 38,290.00
(e) Finance costs 1,760.00 3,060.00
(f) Depreciation, depletion and amortisation expense 4,920.00 9,630.00
(f) Other Expenses
1 Other expenses 32,270.00 54,460.00
Total other expenses 32,270.00 54,460.00
Total expenses 77,620.00 1,38,500.00
3 Total profit before exceptional items and tax 24,320.00 42,880.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 24,320.00 42,880.00
6 Tax expense
7 Current tax 4,360.00 9,240.00
8 Deferred tax 2,620.00 4,080.00
9 Total tax expenses 6,980.00 13,320.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 17,340.00 29,560.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 2,920.00 11,350.00
16 Total profit (loss) for period 20,260.00 40,910.00
17 Other comprehensive income net of taxes 5,050.00 16,150.00
18 Total Comprehensive Income for the period 25,310.00 57,060.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 20,260.00 40,910.00
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 25,310.00 57,060.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 3,580.00 3,580.00
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 11.31 22.84
Diluted earnings (loss) per share from continuing operations 11.31 22.84
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 11.31 22.84
Diluted earnings (loss) per share from continuing and discontinued operations 11.31 22.84
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 2,59,630.00
Capital work-in-progress 39,610.00
Investment property
Goodwill 6,440.00
Other intangible assets 18,500.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method 3,50,340.00
Non-current financial assets
Non-current investments 46,520.00
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Other financial assets 3,100.00
Total of other non-current financial assets 3,100.00
Total non-current financial assets 49,620.00
Deferred tax assets (net) 19,460.00
Other non-current assets
1 Non-current tax assets(Net) 1,290.00
2 Other non-current assets 11,500.00
Total of other non-current assets 12,790.00
Total non-current assets 7,56,390.00
2 Current assets
Inventories 1,00,620.00
Current financial asset
Current investments 44,830.00
Trade receivables, current 80,340.00
Cash and cash equivalents 13,850.00
Bank balance other than cash and cash equivalents 93,050.00
Loans, current 1,060.00
Other current financial assets
Total of other current financial assets 45,020.00
Total current financial assets 2,78,150.00
Current tax assets (net)
Other current assets
1 Other current assets 44,720.00
Total of other current assets 44,720.00
Total current assets 4,23,490.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 11,79,880.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 3,580.00
Other equity 9,72,890.00
Total equity attributable to owners of parent 9,76,470.00
Non controlling interest
Total equity 9,76,470.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease liabilities 280.00
2 Other financial liabilities 580.00
Total of other non-current financial liabilities 860.00
Total non-current financial liabilities 860.00
Provisions, non-current 7,500.00
Deferred tax liabilities (net) 20.00
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 8,380.00
Current liabilities
Current financial liabilities
Borrowings, current 1,02,670.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 2,440.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 40,000.00
Total Trade payable 42,440.00
Other current financial liabilities
1 Other financial liabilities 14,820.00
2 Lease liabilities 390.00
Total of other current financial liabilities 15,210.00
Total current financial liabilities 1,60,320.00
Other current liabilities 17,110.00
1 Other current liabilities 17,110.00
Total of other current liabilities 17,110.00
Provisions, current 11,720.00
Current tax liabilities (Net) 5,880.00
Deferred government grants, Current
Total current liabilities 1,95,030.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 2,03,410.00
Total equity and liabilites 11,79,880.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Pharmaceuticals 90,630.00 1,60,070.00
2 Agro chemicals 6,100.00 10,180.00
Total Segment Revenue 96,730.00 1,70,250.00
Less: Inter segment revenue
Revenue from operations 96,730.00 1,70,250.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Pharmaceuticals 26,070.00 46,460.00
2 Agro chemicals 10.00 (520.00)
Total Profit before tax 26,080.00 45,940.00
i. Finance cost 1,760.00 3,060.00
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax 24,320.00 42,880.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Pharmaceuticals 10,32,230.00 10,32,230.00
2 Agro chemicals 35,550.00 35,550.00
Total Segment Asset 10,67,780.00 10,67,780.00
Un-allocable Assets 1,12,100.00 1,12,100.00
Net Segment Asset 11,79,880.00 11,79,880.00
4 Segment Liabilities
Segment Liabilities
1 Pharmaceuticals 1,68,100.00 1,68,100.00
2 Agro chemicals 8,110.00 8,110.00
Total Segment Liabilities 1,76,210.00 1,76,210.00
Un-allocable Liabilities 27,200.00 27,200.00
Net Segment Liabilities 2,03,410.00 2,03,410.00
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of defined benefit liability/(asset) 0.00 10.00
2 Fair value changes of Equity investments through OCI 120.00 1,150.00
3 Tax impact on Fair value changes on Equity investments through OCI (10.00) (160.00)
Total Amount of items that will not be reclassified to profit and loss 110.00 1,000.00
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
1 Exchange differences on translating financial statements of foreign operations 4,980.00 15,860.00
2 Share of OCI of associate (net of tax) (40.00) (710.00)
Total Amount of items that will be reclassified to profit and loss 4,940.00 15,150.00
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 5,050.00 16,150.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 42,880.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 3,060.00
Adjustments for decrease (increase) in inventories (9,770.00)
Adjustments for decrease (increase) in trade receivables, current 7,820.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets (6,650.00)
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 80.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 1,510.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 9,630.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current (21,990.00)
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 2,960.00
Adjustments for other financial liabilities, non-current (200.00)
Adjustments for unrealised foreign exchange losses gains (390.00)
Adjustments for dividend income 20.00
Adjustments for interest income 9,190.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 220.00
Other adjustments for non-cash items 530.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (22,400.00)
Net cash flows from (used in) operations 20,480.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 3,980.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 16,500.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 1,06,000.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 80.00
Purchase of property, plant and equipment 30,270.00
Proceeds from sales of investment property 18,840.00
Purchase of investment property 23,370.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 480.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 80.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 7,810.00
Interest received 8,980.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 74,010.00
Net cash flows from (used in) investing activities (50,480.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 56,000.00
Repayments of borrowings 24,280.00
Payments of lease liabilities 120.00
Dividends paid 2,710.00
Interest paid 2,750.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 26,140.00
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (7,840.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 1,800.00
Net increase (decrease) in cash and cash equivalents (6,040.00)
Cash and cash equivalents cash flow statement at beginning of period 19,890.00
Cash and cash equivalents cash flow statement at end of period 13,850.00